Goldman Sachs Group Inc Evolus, Inc. Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Evolus, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 361,920 shares of EOLS stock, worth $3.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
361,920
Previous 361,920 -0.0%
Holding current value
$3.36 Million
Previous $4.35 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$9.47 - $15.04 $509,078 - $808,505
-53,757 Reduced 12.93%
361,920 $4.35 Million
Q4 2024

Feb 11, 2025
BUY
$10.84 - $17.45 $1.14 Million - $1.83 Million
105,095 Added 33.84%
415,677 $4.59 Million
Q3 2024

Nov 14, 2024
BUY
$10.66 - $17.48 $1.67 Million - $2.73 Million
156,424 Added 101.47%
310,582 $5.03 Million
Q2 2024

Aug 13, 2024
SELL
$10.45 - $13.76 $335,622 - $441,929
-32,117 Reduced 17.24%
154,158 $1.67 Million
Q1 2024

May 15, 2024
BUY
$9.99 - $14.91 $479,140 - $715,113
47,962 Added 34.68%
186,275 $2.61 Million
Q4 2023

Feb 13, 2024
SELL
$7.6 - $10.53 $257,161 - $356,303
-33,837 Reduced 19.66%
138,313 $1.46 Million
Q3 2023

May 14, 2024
BUY
$7.15 - $10.2 $241,934 - $345,137
33,837 Added 24.46%
172,150 $1.57 Million
Q3 2023

Nov 14, 2023
BUY
$7.15 - $10.2 $10,860 - $15,493
1,519 Added 0.89%
172,150 $1.57 Million
Q2 2023

May 14, 2024
BUY
$7.23 - $10.52 $250,389 - $364,328
34,632 Added 25.46%
170,631 $1.24 Million
Q2 2023

Aug 14, 2023
BUY
$7.23 - $10.52 $250,389 - $364,328
34,632 Added 25.46%
170,631 $1.24 Million
Q1 2023

May 14, 2024
BUY
$7.81 - $11.05 $18,790 - $26,586
2,406 Added 1.8%
135,999 $1.15 Million
Q1 2023

May 11, 2023
BUY
$7.81 - $11.05 $18,790 - $26,586
2,406 Added 1.8%
135,999 $1.15 Million
Q4 2022

May 14, 2024
BUY
$6.52 - $8.95 $272,920 - $374,638
41,859 Added 45.63%
133,593 $1 Million
Q4 2022

Feb 13, 2023
BUY
$6.52 - $8.95 $272,920 - $374,638
41,859 Added 45.63%
133,593 $1 Million
Q3 2022

May 14, 2024
SELL
$7.76 - $13.72 $440,380 - $778,610
-56,750 Reduced 38.22%
91,734 $738,000
Q3 2022

Nov 10, 2022
SELL
$7.76 - $13.72 $440,380 - $778,610
-56,750 Reduced 38.22%
91,734 $738,000
Q2 2022

May 14, 2024
BUY
$10.22 - $13.94 $103,947 - $141,783
10,171 Added 7.35%
148,484 $1.72 Million
Q2 2022

Aug 15, 2022
BUY
$10.22 - $13.94 $602,397 - $821,665
58,943 Added 65.83%
148,484 $1.72 Million
Q1 2022

May 16, 2022
SELL
$5.22 - $11.78 $1.1 Million - $2.49 Million
-211,467 Reduced 70.25%
89,541 $1 Million
Q4 2021

Feb 14, 2022
BUY
$5.37 - $8.38 $51,772 - $80,791
9,641 Added 3.31%
301,008 $1.96 Million
Q3 2021

Nov 10, 2021
BUY
$7.36 - $13.67 $2.14 Million - $3.98 Million
291,367 New
291,367 $2.22 Million

Others Institutions Holding EOLS

# of Institutions
187
Shares Held
52M
Call Options Held
142K
Put Options Held
58.4K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $521M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email